MMMónica Vanessa Mondragón-Gaviria

Mónica Vanessa Mondragón-Gaviria

*This is an algorithmically generated author record based on publicly available information.

Mónica Vanessa Mondragón-Gaviria has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Hypernatremia-associated rhabdomyolysis in paediatric traumatic brain injury

    by Camila Beltrán-Dimas, Monica Mondragón-Gaviria, Juan Javier Peralta-Palmezano, Juan David Roa-Giraldo, Diana Paola Escobar-Serna

    Rhabdomyolysis, a rare condition in the paediatric population, is characterised by the release of intracellular components due to muscle damage. Although various aetiologies have been described, severe hypernatraemia is rarely recognised as a cause. We present a paediatric case of rhabdomyolysis associated with severe hypernatraemia secondary to traumatic brain injury (TBI). A male in early adolescence with severe TBI following a motorcycle accident developed severe hypernatraemia (168 mEq/L) during management in the intensive care unit with hypertonic solution. Creatine kinase levels were elevated up to 30 197 U/L, with transient acute kidney injury. Other causes of rhabdomyolysis were excluded. The patient recovered with conservative management without requiring dialysis. Severe hypernatraemia may be a risk factor for rhabdomyolysis in patients with TBI, potentially mediated by osmotic alterations and cellular damage. This case highlights the importance of monitoring renal function and creatine kinase levels in patients with TBI and electrolyte disturbance. This report underscores the need to consider hypernatraemia as a potential cause of rhabdomyolysis in paediatric patients with TBI. Vigilance and timely management are crucial for the prevention of complications.

  • Open Access

    Terapia de reemplazo renal continua en niños: de los conceptos a la prescripción

    by Oscar Camilo Pantoja-Gómez, Mónica Vanessa Mondragón-Gaviria, Andrea Carolina Lasso-Florez, Rubén Eduardo Lasso-Palomino

    La lesión renal aguda es considerada como una disminución abrupta de la función renal que genera acumulación de productos de desecho, pérdida de balance de líquidos y electrolitos, y alteración de la homeostasis ácido-base. Es una entidad con alta incidencia que afecta a pacientes pediátricos en estado crítico. Uno de cada 10 pacientes afectados por esta patología requerirá terapia de reemplazo renal para su manejo. En la actualidad existe un conjunto de modalidades terapéuticas que permiten la circulación continua de sangre a través de circuitos extracorpóreos con el fin de soportar y/o reemplazar la función normal de los riñones en forma continua durante las 24 horas del día. Tales modalidades se agrupan dentro del término: “Terapia de reemplazo renal continua” (TRRC) y tienen varias ventajas sobre los métodos tradicionales; no obstante, existe entre los profesionales de la salud cierto temor a la hora de prescribir estas terapias debido a su complejidad. En esta revisión de la literatura se presentan los conceptos básicos, modalidades e indicaciones de la TRRC en niños de forma práctica para facilitar su prescripción.


  • Open Access

    Acute renal failure in children. Multicenter prospective cohort study in medium-complexity intensive care units from the Colombian southeast

    by Jaime M. Restrepo, Mónica V. Mondragon, Jessica M. Forero-Delgadillo, Rubén E. Lasso, Eliana Zemanate, Yessica Bravo, Gastón E. Castillo, Stefany Tetay, Natalia Cabal, José A. Calvache

    Acute kidney injury is frequent in critically ill children; however, it varies in causality and epidemiology according to the level of patient care complexity. A multicenter prospective cohort study was conducted in four medium-complexity pediatric intensive care units from the Colombian southeast aimed to estimate the clinical prognosis of patients with diagnosis of acute kidney injury. We included children >28 days and <18 years of age, who were admitted with diagnosis of acute kidney injury classified by Kidney Disease Improving Global Outcomes (KDIGO), during the period from January to December 2017. Severe acute kidney injury was defined as stage 2 and stage 3 classifications. Maximum KDIGO was evaluated during the hospital stay and follow up. Length of hospital stay, use of mechanical ventilation and vasoactive drugs, use of renal replacement therapy, and mortality were assessed until discharge. Prevalence at admission of acute kidney injury was 5.2% (95%CI 4.3% to 6.2%). It was found that 71% of the patients had their maximum KDIGO on day one; an increment in the maximum stage of acute kidney injury increased the pediatric intensive care unit stay. Patients with maximum KDIGO 3 were associated with greater use of mechanical ventilation (47%), compared with maximum KDIGO 2 (37%) and maximum KDIGO 1 (16%). Eight patients with maximum KDIGO 2 and 14 with maximum KDIGO 3 required renal replacement therapy. Mortality was at 11.8% (95%CI 6.4% to 19.4%). Acute kidney injury, established and classified according to KDIGO as severe and its maximum stage, was associated with worse clinical outcomes; early therapeutic efforts should focus on preventing the progression to severe stages.